Pei-yun Li
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cardiorenal Mortality and Safety Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m2: A Target Trial Emulation.
Journal: Diabetes, obesity & metabolism
Published: May 18, 2026
GLP-1 receptor agonists at immune checkpoint inhibitor initiation with immune-related and supportive-care outcomes in patients with cancer and overweight or obesity without diabetes: a target trial emulation.
Journal: Cancer immunology, immunotherapy : CII
Published: April 14, 2026
Microvascular complications and risk of osteoporosis and fractures in type 2 diabetes: a nationwide Asian cohort study.
Journal: Journal of endocrinological investigation
Published: January 09, 2026
Fluoxetine suppresses triple-negative breast cancer progression by inducing apoptosis, inhibiting Src-mediated invasiveness, and enhancing anti-tumor immunity.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 28, 2025
GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and Immune-Related adverse events across cancer types in People with type 2 Diabetes: A Target-Trial emulation.
Journal: Diabetes research and clinical practice
Published: November 07, 2025
Brain activity during cognitive-motor tasks in older adults with cognitive frailty: a fNIRS study.
Journal: Frontiers in aging neuroscience
Published: August 08, 2025
Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 02, 2025
SGLT2 Inhibitors and Prevention of Cardiovascular Events in Diabetes Patients with and Without Hypertension: A Nationwide Cohort Study.
Journal: Journal of general internal medicine
Published: February 27, 2025
Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes.
Journal: Diabetes research and clinical practice
Published: February 07, 2025
Prefrontal activity and heart rate variability during cognitive tasks may show different changes in young and older adults with and without mild cognitive impairment.
Journal: Frontiers in aging neuroscience
Published: February 27, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026